Recombinant Mouse NKG2A Fc Chimera Protein, CF Summary
Accession # Q9Z202
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
When Recombinant Mouse NKG2A Fc Chimera (Catalog # 9198-NK) is coated at 0.5 μg/mL, recombinant human CD94 binds with a typical ED50 of 0.1-0.6 μg/mL.
NKG2A/CD159a is an approximately 40 kDa transmembrane C-type lectin superfamily protein that inhibits innate immune system activation (1). Mouse NKG2A consists of a 70 amino acid (aa) cytoplasmic domain with two ITIM inhibitory motifs, a 23 aa transmembrane segment, and a 151 aa extracellular domain (ECD) with one C-type lectin domain (2). Within the ECD, mouse NKG2A shares 41% and 71% aa sequence identity with human and rat NKG2A, respectively. Alternative splicing generates additional isoforms with a 17 aa deletion in the extracellular juxtamembrane region or a substitution of that region plus the transmembrane segment. NKG2A is expressed on a subset of NK cells and CD8+ T cells (2-6) where it forms a covalent heterodimer with CD94 (5, 7, 8). NKG2A-CD94 heterodimers bind to the widely expressed nonclassical MHC-I molecule, HLA-E (Qa-1b in mouse), which presents a peptide derived from the signal peptide of classical MHC-I molecules (2, 7). Triggering the NKG2A-CD94 complex inhibits the cytolytic activity of NK and CD8+ T cells (2, 3, 5, 6, 9). This enables the innate immune system to detect cells that express host MHC-I molecules and to protect them from NK cell mediated lysis. This mechanism is subverted by human cytomegalovirus which encodes a peptide that is homologous to the HLA-E binding peptide (10). HCMV infected cells up-regulate both HLA-E and NKG2A expression and utilize this peptide to escape from immune clearance (3, 10). In contrast, vaccinia virus induces HLA-E down-regulation, thus permitting NK cell lysis of the virally infected cell (11).
- Das, J. and S.I. Khakoo (2015) Immunol. Rev. 267:214.
- Vance, R.E. et al. (1998) J. Exp. Med. 188:1841.
- Saez-Borderias, A. et al. (2009) J. Immunol.182:829.
- Houchins, J.P. et al. (1997) J. Immunol. 158:3603.
- Brooks, A.G. et al. (1997) J. Exp. Med. 185:795.
- Zhou, J. et al. (2008) J. Immunol. 180:25.
- Braud, V.M. et al. (1998) Nature 391:795.
- Carretero, M. et al. (1997) Eur. J. Immunol. 27:563.
- Lee, N. et al. (1998) Proc. Natl. Acad. Sci. USA 95:5199.
- Tomasec, P. et al. (2000) Science 287:1031.
- Brooks, C.R. et al. (2006) J. Immunol. 176:1141.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Mouse NKG2A Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Mouse NKG2A Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Mouse NKG2A Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image